Company: INDP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021759
Chunk: 100

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 1
Chunk 100
---
ished
    herewith

10

SIGNATURES

Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report
to be signed on its behalf by the undersigned, thereunto duly authorized.

    Indaptus
    Therapeutics, Inc.

    Date:
    November 12, 2025
    By:
    /s/
    Jeffrey A. Meckler

    Jeffrey
    A. Meckler

    Chief
    Executive Officer
    (Principal
    Executive Officer)

    Date:
    November 12, 2025
    By:
    /s/
    Nir Sassi

    Nir
    Sassi

    Chief
    Financial Officer
    (Principal
    Financial and Accounting Officer)

11